viewSativa Group PLC

Sativa Group PLC - Exercise of Options

RNS Number : 0618L
Sativa Group PLC
03 September 2019

3 September 2019

Sativa Group Plc


 ("Sativa" or "the Group" or "the Company")


Exercise of Options


Sativa Group Plc (NEX: SATI), announces that it has allotted 7,000,000 new ordinary shares of 0.25 pence each in the Company ("Ordinary Shares") pursuant to the exercise of share options.  Application has been made for the new Ordinary Shares to be admitted to trading on the NEX Exchange Growth Market ("Admission") and Admission is expected to become effective on 9 September 2019.


The option holder has exercised 7,000,000 options with an exercise price of 0.5p.  Gross proceeds of £35,000 have been received by the Company and will be used for general working capital purposes.  The option holder is restricted from disposing of shares or any interest in shares until 30 August 2020 without the approval of Cenkos Securities, the Company's Corporate Adviser. 


The new Ordinary Shares will rank pari passu in all respects with the existing Ordinary Shares of the Company. 


Following Admission, the Company's issued share capital will comprise 534,689,167 Ordinary Shares, which number may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.  The Company does not hold any shares in treasury.


-  Ends  -


For further information please contact:


Henry Buckley

Chief Executive Officer

Sativa Investments PLC

+44 (0) 20 7971 1255

[email protected]

Joseph Colliver

Chief Financial Officer

Sativa Investments PLC

+44 (0) 20 7971 1255

[email protected]


NEX Exchange Corporate Adviser


Corporate Finance 


Stephen Keys / Max Gould 

Cenkos Securities plc 

+44 (0) 20 7397 8900


Equity Sales 


Julian Morse

Cenkos Securities

+44 (0) 20 7397 8900



Financial PR and IR


Abchurch Communications

Julian Bosdet

+44 (0) 20 7459 4070 

+44 (0) 7771 663 886 

[email protected]









This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

Quick facts: Sativa Group PLC

Price: 2.35

Market: AQSE
Market Cap: -

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...



Sativa Investments PLC acquires UK-based PhytoVista Laboratories

Geremy Thomas, chief executive of Sativa Investments PLC (AQSE:SATI), tells Proactive's Andrew Scott they've agreed to buy PhytoVista Laboratories, a UK-based lab that tests cannabis oils and hemp products, for £435,000. The British medicinal cannabis investment vehicle will pay £235,000...

on 4/7/18